scholarly journals Dual Contraception Use and Associated Factors among HIV Positive Women Follow-Up at Treatment Center Unit of Yaounde Central Hospital, Cameroon

OALib ◽  
2020 ◽  
Vol 07 (05) ◽  
pp. 1-12
Author(s):  
Marcellin Tsafack ◽  
Felix Essiben ◽  
Romaric Joel Momo ◽  
Georges Pius Kamsu Moyo ◽  
Yannick Massaga Mpoah ◽  
...  
Keyword(s):  
Associated Factors ◽  
Treatment Center ◽  
Hiv Positive ◽  
Central Hospital ◽  
Hiv Positive Women ◽  
Contraception Use

scholarly journals Contraceptive use and associated factors among sexually active HIV positive women attending ART clinic in FHRH in Bahir Dar, north west, Ethiopia, 2018. Facility based cross-sectional study.

2019 ◽  
Author(s):  
tilksew ayalew ◽  
Tilahun Tewabe ◽  
Abdulhakim Abdanur ◽  
Demoze Jenbere ◽  
Mastewal Ayehu ◽  
...  
Keyword(s):  
Associated Factors ◽  
Contraceptive Use ◽  
Cross Sectional Study ◽  
Hiv Positive ◽  
Sexually Active ◽  
Cross Sectional ◽  
North West ◽  
Hiv Positive Women ◽  
Contraception Use ◽  
Human Immune

Abstract Abstract Back ground: Contraception helps prevent unplanned pregnancies and mother to child HIV transmission among human immune virus positive women. Contraceptive use status and associated factors were not well addressed in the study area. This study aimed to assess contraceptives use and associated factors among HIV positive sexually active women at anti-retroviral therapy clinic in Felege Hiwot Referral Hospital, Northwest Ethiopia. Method : A facility based quantitative cross-sectional study was conducted from June 01 -30, 2018, among 308 randomly selected sexually active HIV positive women of reproductive age in Felege Hiwot Referral Hospital anti-retro viral treatment clinic. A pre-tested interviewer-administered questionnaire was used to collect data. Data were analyzed using SPSS version20. Descriptive statistics were used to summarize socio-demographic characteristics of participants. A multivariate logistic regression analysis method was employed and odds ratio with 95% confidence interval was used to control possible confounders. Statistical significance was declared at p-value <0.05. Results: The current study revealed that overall contraception use among sexually active HIV positive women was 38.3 %( 95%CI: 32.5%-43.5%). Women with age range of 15-34 years old (AOR =3.089, 95%CI: 1.591-5.999), HIV status disclosure to sex partner, (AOR=2.75995%CI: 1.142-6.663), previous contraception utilization experience; (AOR=3.361, 95%CI: 1.677-6.736), Sexual activity in the last six months (AOR5.451, 95%CI: 2.724-10.908) and had drinking habit (AOR=4.351, 95%CI: 1.824-10.379) were the main predictors of contraceptive use. Conclusion: Contraceptive use was low in the current study area. Efforts should be strengthened to increase contraception use among human immune virus positive women. Anti-retro viral treatment and family planning services should be integrated to increase contraceptive use uptake in the study area. Keywords: Contraceptive use, Contraception, Human immune virus positive women, Bahir Dar, North west Ethiopia.

scholarly journals Prevalence of HIV and Associated Factors among Infants Born to HIV Positive Women in Amhara Region, Ethiopia

2014 ◽  
Vol 05 (08) ◽  
pp. 464-474 ◽  
Author(s):  
Zelalem Berhan ◽  
Fantu Abebe ◽  
Molla Gedefaw ◽  
Mulugeta Tesfa
Keyword(s):  
Associated Factors ◽  
Hiv Positive ◽  
Amhara Region ◽  
Hiv Positive Women

Fertility desire and associated factors among ART user reproductive-age women in public health facility in Gondar city administration Northwest Ethiopia

2020 ◽  
Author(s):  
Eyob Araya Gebrekidan ◽  
Alehegn Bishaw Geremew ◽  
Telake Azale Bisetegn
Keyword(s):  
Health Care ◽  
Antiretroviral Therapy ◽  
Associated Factors ◽  
Reproductive Age ◽  
Family Influence ◽  
Hiv Positive ◽  
Fertility Desire ◽  
Binary Logistic Regression Model ◽  
Reproductive Age Women ◽  
Hiv Positive Women

Abstract Background: Antiretroviral therapy scales up globally and in Ethiopia, as a result, AIDS-related mortality has reduced, but the number of new HIV infections increasing. Antiretroviral therapy in Ethiopia gives a chance of living longer for reproductive-age women. Prevention of pregnancy among HIV positive women is the second WHO prongs of HIV transmission with respecting women’s reproductive rights. Antiretroviral therapy uses improve the health of HIV positive women using and women's fertility desire increasing. Therefore this study aimed to assess the fertility desire and associated factors among ART user reproductive-age women. Methods: A facility-based cross-sectional study design conducted from November 2-30/2018. The calculated sample size was 400 and study participants were selected by using systematic random sampling. A pre-tested structured questionnaire was used to collect data. A binary logistic regression model was employed and adjusted odds ratio with a 95% confidence interval used to consider statistically significant Results: A total of 397 clients were participated in the study, giving a response rate of 99.3%. The proportion of fertility desire in this study was 55.2 %(95% CI, 50.4%- 60.2%). A duration of marriage < 4 year [AOR=6.9(95 CI: 1.65, 28.81)], and 5–9 years duration of marriage [AOR= 13.8 (95% CI: 2.39, 80.39)] higher as compared to 15 years and above, family influence 3.4 times more likely to have fertility desire than have no family influence [AOR= 3.4 (95% CI: 1.06, 11.25)], partner desire 4.3 times more likely have had fertility desires as compared to with counterpart [AOR= 4.3 (95% CI: 1.93,9.41)], and discussion with health care provider 66 % less likely to have fertility desire as compared with counterpart [AOR = 0.34 (95% CI: 0.39, 3.31)]. Conclusion: In this study, we have identified a high proportion of fertility desire among ART user reproductive-age women. The duration of marital status, partner influence, family influence, and discussion of health care were associated with fertility desire. Family-oriented counseling, partner involvement on reproductive health services should be encouraged to support the rights of all women to safely achieve their fertility. Keywords: Fertility desire, reproductive age, women on ART.

scholarly journals Describing Point of Entry into Care and Being Lost to Program in a Cohort of HIV Positive Pregnant Women in a Large Urban Centre in Uganda

2017 ◽  
Vol 2017 ◽  
pp. 1-6 ◽  
Author(s):  
Rachel Musomba ◽  
Frank Mubiru ◽  
Shadia Nakalema ◽  
Hope Mackline ◽  
Ivan Kalule ◽  
...  
Keyword(s):  
Pregnant Women ◽  
Older Women ◽  
First Trimester ◽  
Hiv Positive ◽  
Urban Centre ◽  
Factors Associated ◽  
Point Of Entry ◽  
Art Initiation ◽  
Hiv Positive Women

Introduction. We aim to describe the time of entry into care and factors associated with being lost to program (LTP) in pregnant women on Option B Plus in an integrated HIV and antenatal care (ANC) clinic in Uganda. Methods. We included all pregnant women enrolled into the integrated HIV-ANC clinic from January 2012 to 31st July 2014, while the follow up period extended up to October 30th 2015. LTP was defined as being out of care for ≥3 months. Results. Overall 856 women were included. Only 36.4% (86/236) of the women were enrolled in the first trimester. Overall 69 (8.1%) were LTP. In the multivariate analysis older women (HR: 0.80 per five-year increase, CI: 0.64–1.0, and P=0.060) and women on ART at the time of pregnancy (0.58, CI: 0.34–0.98, and P=0.040) were more likely not to be LTP. Among women already on ART at the time of pregnancy no factor was associated with LTP. Conclusion. Our results suggest the need for interventions to enhance prompt linkage of HIV positive women to HIV services for ART initiation and for increased retention particularly in young and ART naive women.

Successful Community Follow-up and Reduced Recidivism in HIV Positive Women Prisoners

1997 ◽  
Vol 4 (1) ◽  
pp. 5-17 ◽  
Author(s):  
Joo Y. Kim ◽  
Josiah Rich ◽  
Sally Zierler ◽  
Kevin Lourie ◽  
Kevin Vigilante ◽  
...  
Keyword(s):  
Women Prisoners ◽  
Hiv Positive ◽  
Hiv Positive Women

scholarly journals Challenges in Assessing Outcomes among Infants of Pregnant HIV-Positive Women Receiving ART in Uganda

2017 ◽  
Vol 2017 ◽  
pp. 1-4
Author(s):  
Barbara Castelnuovo ◽  
Frank Mubiru ◽  
Ivan Kalule ◽  
Shadia Nakalema ◽  
Agnes Kiragga
Keyword(s):  
Clinical Trials ◽  
Pregnant Women ◽  
Median Time ◽  
Hiv Transmission ◽  
Cd4 Count ◽  
Hiv Positive ◽  
Hiv Positive Women

Since 2012, the WHO recommends lifelong ART with TDF+FTC/3TC+EFV for all HIV-positive pregnant and breastfeeding women (Option B-plus). In this analysis we describe the proportion of early and late transmission in mothers with high retention in Kampala, Uganda. We included 700 pregnant women from January 2012 to August 2014 with a follow-up extended to August 2016; the median age was 31 years (IQR: 26–35), 36.3% in WHO stage 3/4; median CD4 count was 447 cells/μL (IQR: 301–651) and 73.3% were already on ART for a median time of 28 (IQR: 10–57) months; 52% infants were male and median weight was 3.2 Kg (IQR: 2.5–3.5). Five hundred and sixty-five (80.7%) infants had at least one test for HIV; 22 (3.1%) infants died, all with unknown serostatus; 3 tested positive at week 6 and one additional at months 12 and 18. Two of the mothers of the 4 HIV-positive infants were ART-naïve at the time of pregnancy. We report very low documented HIV transmission comparable with those reported in clinical trials settings; however, demonstrating the efficacy of Option B-plus in terms of averted transmission in routine settings is challenging since high proportion of infants do not have documented HIV tests.

scholarly journals A prospective study of demographic features and quality of life in HIV-positive women with cervical cancer treated at Tygerberg Hospital

2015 ◽  
Vol 16 (1) ◽  
Author(s):  
George Du Toit ◽  
Martin Kidd
Keyword(s):  
Quality Of Life ◽  
Cervical Cancer ◽  
Cancer Treatment ◽  
Hiv Positive ◽  
Hiv Positive Women ◽  
Eortc Qlq C30 ◽  
Eortc Qlq ◽  
Hiv Negative

Background: Cervical cancer and human immunodeficiency virus (HIV) infection/acquired immune deficiency syndrome (AIDS) both have a high incidence in South Africa. Cervical cancer treatment of HIV-positive women poses challenges. Treatment-related changes in quality of life (QOL) of such women are important to future treatment protocols.Aim: To examine demographic data of HIV-negative and HIV-positive women at diagnosis of cervical cancer and describe their changes in QOL as a result of treatment.Methods and materials: All newly diagnosed patients with cervical cancer at Tygerberg Hospital were approached to participate in the study. The European Organisation for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30) and the Cervix Cancer Module (QLQ-CX24) were used. General QOL was measured with the EORTC QLQ-C30 and cervical-specific QOL with the QLQ-CX24 questionnaire. The patients completed the questionnaire at diagnosis, on completion of treatment and at 3 months’ follow-up.Results: The study included a total of 221 women of whom 22% were HIV-positive; the latter were younger and of higher educational level than the rest. Mean monthly income and stage distribution was similar between the two groups. HIV-positive patients underwent radiation therapy more commonly than chemoradiation. HIV-positive women showed statistically significantly higher loss to follow-up during the study. HIV-positive women experienced no improvement in insomnia, appetite loss, nausea, vomiting, diarrhoea, social role or any of the sexual domains. In contrast, HIV-negative women experienced statistically significant improvement in all sexual domains other than sexual/vaginal functioning. The QOL improvement of HIV-negative women was statistically significantly greater than their HIV-positive counterparts in the majority of QOL domains. Global health improved in both groups, with HIV-negative women experiencing greater improvement. HIV-positive women experienced an initial decline of peripheral neuropathy (PN) symptoms post treatment with a return to pretreatment values at 3 months’ follow-up. The change in PN was statistically significant between the HIV-negative and HIV-positive women.Conclusion: Demographic differences exist between the HIV-negative and HIV-positive groups. The differential outcome in the QOL of HIV-positive and HIV-negative women treated for cervical cancer might be related to persistence of AIDS-related symptoms on completion of cervical cancer treatment.

Sign in / Sign up

Export Citation Format

Share Document